3D MR neurography targeted peripheral nerve ablation with MR-guided high intensity focused ultrasound (MR-HIFU): initial results of a feasibility study in a swine model

Abstract

Background/introduction: MR-guided HIFU is an effective treatment for metastatic bone pain through periosteal nerve ablation, [1] and is being investigated for treating back pain through facet joint denervation [2]. For peripheral neuropathy, ultrasound-guided HIFU has been investigated preclinically as a means of achieving either an irreversible conduction block to treat severe spasticity, [3] or a reversible partial conduction block to alleviate chronic pain [4]. However, ultrasound offers limited visualization of deeply situated pelvic nerves [5] and lacks the ability to measure thermal dose, which predicts the extent of changes in peripheral nerve histology and function [6]. Recently developed diffusion-prepared 3D MR neurography imaging techniques with fat suppression and nerve-selective T2-weighting [7] could improve targeting accuracy over ultrasound guidance. We present initial investigations into the use of MRI to guide HIFU ablation of peripheral nerves in a swine model. The objectives were 1) to evaluate the feasibility of identifying peripheral (Figure Presented) nerves using MR neurography on the clinical MR-HIFU system, 2) to monitor HIFU ablation of peripheral nerves using MR thermometry, and 3) to evaluate the ability to measure thermal lesions in peripheral nerves using contrast-enhanced T1-weighted images and thermal dose maps calculated from MR thermometry. Methods: Experiments were approved by the local Institutional Animal Care and Use Committee. Volumetric MR-HIFU was used to induce seven thermal lesions in the sciatic nerves of three pigs. 3D MR neurography and T1-weighted images at 3T were used for target identification and treatment planning. A single 8 or 12 mm treatment cell was used to cover the full width of each targeted nerve. Ultrasound exposures were performed under MR thermometry guidance in five image planes across the HIFU beam, and one plane along the beam axis. Sonications were performed at 1.2 MHz with acoustic power ranging from 160 to 300 W over fixed durations of 20 or 36 seconds (energy 3.2 to 10.8 kJ). Ablation dimensions were measured and compared using thermal dose maps, contrast-enhanced T1-weighted images, and gross pathology. Results and conclusions: All targeted sciatic nerves were identifiable on MR neurography and T1-weighted images (Fig 1). For sonications at 160 to 300 W, MR thermometry measured peak temperatures of 60.3 to 85.7° C, with 240 equivalent minute thermal dose diameters of 8.5 to 15.9 mm (Fig 2). Thermal lesions were visible on late phase contrast-enhanced T1 (Fig 3), with dimensions matching the coagulated region observed at necropsy (Fig 4). Our preliminary results indicate that targeted peripheral nerve ablation is feasible with MR-HIFU. Diffusion-prep 3D MR neurography has potential for guiding therapy procedures where either nerve targeting or avoidance is desired.